Athira Pharma Stock Forward View

Athira Pharma Additional Predictive Modules

Most predictive techniques to examine Athira price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Athira using various technical indicators. When you analyze Athira charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Athira Pharma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Athira Pharma value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Athira Pharma Naive Prediction Price Forecast For the 31st of January

Given 90 days horizon, the Naive Prediction forecasted value of Athira Pharma on the next trading day is expected to be 5.07 with a mean absolute deviation of 0.40, mean absolute percentage error of 0.28, and the sum of the absolute errors of 24.43.

Athira Pharma Stock Forecast Pattern

Backtest Athira Pharma

Athira Pharma Price Prediction

Buy or Sell Advice

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Athira Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Athira Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Athira Pharma. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Athira Pharma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Athira Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Athira Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.32 6.49 16.53 Details

Intrinsic Valuation Low Real High 0.26 5.15 15.19 Details

Bollinger Band Projection (param) Low Middle High 3.26 6.16 9.06 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Athira Pharma. Your research has to be compared to or analyzed against Athira Pharma's peers to derive any actionable benefits. When done correctly, Athira Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Athira Pharma.

Athira Pharma After-Hype Price Density Analysis

Athira Pharma Estimiated After-Hype Price Volatility

Athira Pharma Stock Price Outlook Analysis

Notes

Athira Pharma Hype Timeline

Athira Pharma is presently traded for 6.55. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of 0.09. Athira is forecasted to decline in value after the next headline, with the price expected to drop to 6.49. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.92%, whereas the daily expected return is presently at 1.3%. The volatility of related hype on Athira Pharma is about 14140.85%, with the expected price after the next announcement by competition of 6.64. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.99. Some equities with similar Price to Book (P/B) outperform the market in the long run. Athira Pharma recorded a loss per share of 9.67. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 18th of September 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 4 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Athira Pharma Related Hype Analysis

Athira Pharma Related Equities

Risk & Return

Correlation

Athira Pharma Market Strength Events

Athira Pharma Risk Indicators

Story Coverage note for Athira Pharma

Athira Pharma Short Properties

Other Consideration for investing in Athira Stock